Suppr超能文献

使用改良的CPD血袋储存儿科患者体外膜肺氧合(ECMO)或肾脏替代治疗(RRT)回路中的血液。

Using a Modified CPD Blood Bag to Store Blood from either ECMO or RRT Circuit Blood in Pediatric Patients.

作者信息

Neal James R, Friedrich Tammy P, Schears Gregory J, Cramer Carl H

机构信息

Department of Cardiac Surgery, Department of Nursing, Department of Anesthesiology and Critical Care Medicine, and Division of Pediatric Nephrology, Mayo Clinic, Rochester, Minnesota.

出版信息

J Extra Corpor Technol. 2020 Jun;52(2):146-150. doi: 10.1182/ject-2000017.

Abstract

By adapting a citrate phosphate dextrose (CPD) whole blood storage bag, residual blood from a renal replacement therapy (RRT) circuit can be saved in pediatric patients, decreasing in donor exposure later. The techniques used for autologous preoperative blood storage are the basis of storing the RRT circuit blood. The CPD anticoagulant has a benefit of having a commonly used reversal agent for its anticoagulant properties, i.e., calcium. Also, unlike the traditional anticoagulants used in extracorporeal membrane oxygenation (ECMO), i.e., heparin, and direct thrombin inhibitors, i.e., bivalirudin, there is no increase in anticoagulation laboratory parameters after administration. The CPD volume in the bag is reduced but keeps the original ratio the same between CPD and blood. This is accomplished by removing all CPD from the bag, adding back only the exact amount of CPD needed for the smaller amount of blood being transferred from the circuit. The RRT circuit managed at our institution uses 23 mL of CPD for 165 mL of circuit blood when stored with this technique. This calculation assumes a normal patient calcium level. This technique has been used successfully multiple times in more than 30 pediatric patients without incident for 7 years at our center. The CPD bag can also be used to store the residual blood from ECMO circuits after removal of ECMO to allow the blood to be given back to the patient at a later time by keeping the same citrate-to-blood ratio.

摘要

通过改造枸橼酸盐磷酸盐葡萄糖(CPD)全血储存袋,可将儿科患者肾替代治疗(RRT)回路中的残余血液保存下来,减少日后对供血者的接触。用于术前自体血储存的技术是储存RRT回路血液的基础。CPD抗凝剂的一个优点是其抗凝特性有常用的逆转剂,即钙。此外,与体外膜肺氧合(ECMO)中使用的传统抗凝剂(即肝素)和直接凝血酶抑制剂(即比伐卢定)不同,给药后抗凝实验室参数不会增加。袋中CPD的体积减少,但CPD与血液之间的原始比例保持不变。这是通过从袋中取出所有CPD,仅添加从回路转移的较少量血液所需的确切CPD量来实现的。使用该技术储存时,我们机构管理的RRT回路每165 mL回路血液使用23 mL CPD。该计算假设患者钙水平正常。在我们中心,该技术已在30多名儿科患者中成功使用多次,7年来无不良事件发生。在去除ECMO后,CPD袋还可用于储存ECMO回路中的残余血液,通过保持相同的枸橼酸盐与血液比例,以便日后将血液回输给患者。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验